RMFCX
Price
$61.51
Change
+$0.17 (+0.28%)
Updated
Oct 17 closing price
Net Assets
111.18B
TRLCX
Price
$24.54
Change
+$0.15 (+0.62%)
Updated
Oct 17 closing price
Net Assets
6.17B
Interact to see
Advertisement

RMFCX vs TRLCX

Header iconRMFCX vs TRLCX Comparison
Open Charts RMFCX vs TRLCXBanner chart's image
American Funds American Mutual R3
Price$61.51
Change+$0.17 (+0.28%)
VolumeN/A
Net Assets111.18B
Nuveen Large Cap Value Retire
Price$24.54
Change+$0.15 (+0.62%)
VolumeN/A
Net Assets6.17B
RMFCX vs TRLCX Comparison Chart in %
View a ticker or compare two or three
VS
RMFCX vs. TRLCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and TRLCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 111B vs. TRLCX (6.17B). RMFCX pays higher dividends than TRLCX: RMFCX (1.20) vs TRLCX (1.13). RMFCX was incepted earlier than TRLCX: RMFCX (23 years) vs TRLCX (23 years). RMFCX (0.91) is less costly to investors than TRLCX (0.66). RMFCX is a more actively managed with annual turnover of: 31.00 vs. TRLCX (19.00). TRLCX has a lower initial minimum investment than RMFCX: TRLCX (0) vs RMFCX (250). RMFCX (4.96) and TRLCX (4.84) have marching annual gain over last year. RMFCX return over 5 years is better than : 57.10 vs. TRLCX (53.74).
RMFCXTRLCXRMFCX / TRLCX
Total Expense Ratio0.910.66138%
Annual Report Gross Expense Ratio0.910.66138%
Fund Existence23 years23 years-
Gain YTD13.68911.647118%
Front LoadN/AN/A-
Min. Initial Investment2500-
Min. Initial Investment IRAN/AN/A-
Net Assets111B6.17B1,800%
Annual Yield % from dividends1.201.13107%
Returns for 1 year4.964.84102%
Returns for 3 years38.7935.30110%
Returns for 5 years57.1053.74106%
Returns for 10 years91.1853.02172%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FACSX52.870.36
+0.69%
Nuveen Mid Cap Value Opportunities C
TRIEX28.680.06
+0.21%
Nuveen International Eq Idx Retire
FACTX53.840.05
+0.09%
Fidelity Advisor Health Care M
DASVX15.17-0.02
-0.13%
Dunham Small Cap Value A
BIEMX15.70-0.13
-0.82%
William Blair Emerging Mkts Growth R6